Identifying at risk infants following neonatal extracorporeal membrane oxygenation

Journal of Perinatology

Volumn 19, Issue 5, 1999, Pages 367-372

  Kumar, Praveen ^a,b   Shankaran, Seetha ^a   Bedard, Mary P ^a   Delaney Black, Virginia ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUSE OF DEATH; CHILD DEVELOPMENT; DEVELOPMENTAL DISORDER; EXTRACORPOREAL OXYGENATION; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT MORTALITY; LONGITUDINAL STUDY; NERVOUS SYSTEM; NEWBORN; RISK FACTOR; SURVIVAL;

CAUSE OF DEATH; CHILD DEVELOPMENT; DEVELOPMENTAL DISABILITIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FOLLOW-UP STUDIES; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; LONGITUDINAL STUDIES; NERVOUS SYSTEM; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0033154831     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200195     Document Type: Article

References (25)

1. ECMO registry report of the Extracorporeal Life Support Organization: international summary. Ann Arbor, MI: The Organization; October 1994.
2. Krummel TM, Greenfield LJ, Kirkpatrick BV, et al. The early evaluation of survivors after extracorporeal membrane oxygenation for neonatal pulmonary failure. J Pediatr Surg 1984;19:585-90.
3. Andrews AF, Nixon CA, Cilley RE, Roloff DW, Bartlett RH. One to three year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. Pediatrics 1986;78:692-8.
4. Hofkosh D, Thompson AE, Nozza RJ, Kemp SS, Bowen A, Feldman HM. Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics 1991;87:549-55.
5. Glass P, Miller M, Short BL. Morbidity for survivors of extracorporeal membrane oxygenation: neurodevelopmental outcome at 1 year of age. Pediatrics 1989;83: 72-8.
6. Wildin SR, Landry SH, Zwischenberger JB. Prospective, controlled study of developmental outcome in survivors of extracorporeal membrane oxygenation: the first 24 months. Pediatrics 1994;93:404-8.
7. Walsh-Sukys MC, Bauer RE, Cornell DJ, Friedman HG, Stork EK, Hack M. Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes. J Pediatr 1994;125:104-10.
8. Robertson CMT, Finer NN, Sauve RS, et al. Neurodevelopmental outcome after neonatal extracorporeal membrane oxygenation. Can Med Assoc J 1995;152: 1981-8.
9. Glass P, Wagner AE, Papero PH, et al. Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 1995;127:447-57.
10. Vaucher YE, Dudell GG, Bejar R, Gist K. Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. J Pediatr 1996;128:109-17.
11. Bayley N. Bayley Scales of Infant Development. New York: The Psychological Corporation; 1969.
12. McCarthy D. Manual for the McCarthy Scale of Children's Abilities. New York: The Psychological Corporation; 1972.
13. Shankaran S, Woldt E, Koepke T, Bedard MP, Nandyal R. Acute neonatal morbidity and long term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev 1991;25:135-48.
14. Bartlett RH, Stolar C. Extracorporeal life support: state of the art 1990. In: Wright LL, editor. Report of the Workshop on Diffusion of ECMO Technology. Washington, DC: National Institutes of Health; 1993.
15. Weber TR, Connors RH, Tracy TF, Bailey PV, Stephens C, Keenan W. Prognostic determinants in extracorporeal membrane oxygenation for respiratory failure in newborns. Ann Thorac Surg 1990;50:720-3.
16. Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983;103:505-14.
17. Hageman JR, Adams MA, Gardner TH. Pulmonary complications of hyperventilation therapy for persistent pulmonary hypertension. Crit Care Med 1985;13:1013-4.
18. Hansen NB, Nowicki PT, Miller RR, Malone T, Bickers RG, Menke JA. Alterations in cerebral blood flow and oxygen consumption during prolonged hypocarbia. Pediatr Res 1986;20:147-50.
19. Bifano EM, Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988;81:657-61.
20. Sell EJ, Gaines JA, Gluckman C, Williams E. Persistent fetal circulation: neurodevelopmental outcome. Am J Dis Child 1985;139:25-8.
21. BembaumJC, Russell P, Sheridan PH, Gewitz MH, Fox WW, Peckham GJ. Long-term follow-up of newborns with persistent pulmonary hypertension. Crit Care Med 1984;12:579-83.
22. Ferrara B, Johnson DE, Chang PN, Thompson TR. Efficacy and neurologic outcome of profound hypocapneic alkalosis for the treatment of persistent pulmonary hypertension in infancy. J Pediatr 1984;105:457-61.
23. John E, Roberts V, Burnard ED. Persistent pulmonary hypertension of the newborn treated with hyperventilation: clinical features and outcome. Aust Paeditr J 1988;24:357-61.
24. Glass P. Outcome after neonatal ECMO. In: Arensman R, Cornish D, editors. Extracorporeal Life Support. Cambridge, MA: Blackwell; 1990.
25. Casaer P, Lagae L Age specific approach to neurological assessment in the first year of life. Acta Pediatr Jpn 1991;33:125-38.